A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome - PubMed (original) (raw)
A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome
J Guy et al. Nat Genet. 2001 Mar.
Abstract
Rett syndrome (RTT) is an inherited neurodevelopmental disorder of females that occurs once in 10,000-15,000 births. Affected females develop normally for 6-18 months, but then lose voluntary movements, including speech and hand skills. Most RTT patients are heterozygous for mutations in the X-linked gene MECP2 (refs. 3-12), encoding a protein that binds to methylated sites in genomic DNA and facilitates gene silencing. Previous work with Mecp2-null embryonic stem cells indicated that MeCP2 is essential for mouse embryogenesis. Here we generate mice lacking Mecp2 using Cre-loxP technology. Both Mecp2-null mice and mice in which Mecp2 was deleted in brain showed severe neurological symptoms at approximately six weeks of age. Compensation for absence of MeCP2 in other tissues by MeCP1 (refs. 19,20) was not apparent in genetic or biochemical tests. After several months, heterozygous female mice also showed behavioral symptoms. The overlapping delay before symptom onset in humans and mice, despite their profoundly different rates of development, raises the possibility that stability of brain function, not brain development per se, is compromised by the absence of MeCP2.
Similar articles
- Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.
Chen RZ, Akbarian S, Tudor M, Jaenisch R. Chen RZ, et al. Nat Genet. 2001 Mar;27(3):327-31. doi: 10.1038/85906. Nat Genet. 2001. PMID: 11242118 - Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.
Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Amir RE, et al. Nat Genet. 1999 Oct;23(2):185-8. doi: 10.1038/13810. Nat Genet. 1999. PMID: 10508514 - Rett syndrome: the complex nature of a monogenic disease.
Renieri A, Meloni I, Longo I, Ariani F, Mari F, Pescucci C, Cambi F. Renieri A, et al. J Mol Med (Berl). 2003 Jun;81(6):346-54. doi: 10.1007/s00109-003-0444-9. Epub 2003 May 16. J Mol Med (Berl). 2003. PMID: 12750821 Review. - X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain.
Braunschweig D, Simcox T, Samaco RC, LaSalle JM. Braunschweig D, et al. Hum Mol Genet. 2004 Jun 15;13(12):1275-86. doi: 10.1093/hmg/ddh142. Epub 2004 Apr 28. Hum Mol Genet. 2004. PMID: 15115765 - Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
Filosa S, Pecorelli A, D'Esposito M, Valacchi G, Hajek J. Filosa S, et al. Free Radic Biol Med. 2015 Nov;88(Pt A):81-90. doi: 10.1016/j.freeradbiomed.2015.04.019. Epub 2015 May 8. Free Radic Biol Med. 2015. PMID: 25960047 Review.
Cited by
- Kynurenine pathway metabolism following prenatal KMO inhibition and in Mecp2+/- mice, using liquid chromatography-tandem mass spectrometry.
Forrest CM, Kennedy PG, Rodgers J, Dalton RN, Turner C, Darlington LG, Cobb SR, Stone TW. Forrest CM, et al. Neurochem Int. 2016 Nov;100:110-119. doi: 10.1016/j.neuint.2016.09.012. Epub 2016 Sep 10. Neurochem Int. 2016. PMID: 27623092 Free PMC article. - Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes.
Wang H, Pati S, Pozzo-Miller L, Doering LC. Wang H, et al. Front Cell Neurosci. 2015 Feb 26;9:55. doi: 10.3389/fncel.2015.00055. eCollection 2015. Front Cell Neurosci. 2015. PMID: 25767435 Free PMC article. Review. - MeCP2 modulates gene expression pathways in astrocytes.
Yasui DH, Xu H, Dunaway KW, Lasalle JM, Jin LW, Maezawa I. Yasui DH, et al. Mol Autism. 2013 Jan 25;4(1):3. doi: 10.1186/2040-2392-4-3. Mol Autism. 2013. PMID: 23351786 Free PMC article. - Loss of MeCP2 disrupts cell autonomous and autocrine BDNF signaling in mouse glutamatergic neurons.
Sampathkumar C, Wu YJ, Vadhvani M, Trimbuch T, Eickholt B, Rosenmund C. Sampathkumar C, et al. Elife. 2016 Oct 26;5:e19374. doi: 10.7554/eLife.19374. Elife. 2016. PMID: 27782879 Free PMC article. - Novel CDKL5 targets identified in human iPSC-derived neurons.
Massey S, Ang CS, Davidson NM, Quigley A, Rollo B, Harris AR, Kapsa RMI, Christodoulou J, Van Bergen NJ. Massey S, et al. Cell Mol Life Sci. 2024 Aug 13;81(1):347. doi: 10.1007/s00018-024-05389-8. Cell Mol Life Sci. 2024. PMID: 39136782 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases